You are here

Novartis begins trial of new antimalarial drug


NOVARTIS is taking aim at drug-resistant malaria - a growing global problem - by launching clinical trials of the first new antimalarial medicine for many years in nine countries across Africa and Asia.

The Swiss drugmaker, which is working on the mid-stage Phase IIb trial...

Market voices on: